Ucb and amgen initiate sclerostin antibody phase 3 program in patients with postmenopausal osteoporosis Full Text
Amgen,

UCB and Amgen announced the start of their sclerostin antibody (CDP7851/AMG 785) Phase 3 clinical trial program for the treatment of postmenopausal osteoporosis.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Pharma News

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pharma News Articles

1 A statin a day to keep the doctor away? comparing aspirin and statins for primary prevention of cardiovascular disease Annals of Pharmacotherapy, August 7, 2014    Clinical Article

2 Safety of new drugs questioned by researchers Full Text Formulary , August 22, 2014    Free full text

3 Report predicts generics production return to US Full Text BioPharm International, August 19, 2014    Free full text

4 More DAAs, more controversy Full Text Applied Clinical Trials, August 29, 2014    Free full text

5 Americas "Great Generic Wars" and the Canadian-European Trade Agreement Pharmaceutical Executive Magazine, August 27, 2014

6 Shimadzu Pharmaceutical Executive Magazine, August 21, 2014

7 FDA warns about fraudulent Ebola treatments Full Text BioPharm International, August 18, 2014    Free full text

8 FDA accepts first biosimilar filing Full Text BioPharm International, August 4, 2014    Free full text

9 Pharm execs 2014 emerging pharma leaders Pharmaceutical Executive Magazine, August 8, 2014

10 Ebola vaccine using DepoVax shows positive results Full Text BioPharm International, August 28, 2014    Free full text

11 Topical administration of lacritin is a novel therapy for aqueous-deficient dry eye disease. Investigative Ophthalmology & Visual Science, August 8, 2014    Clinical Article

12 New blockbuster drugs will more than Triple Acute Coronary Syndrome treatment market value by 2023 Full Text BioPharm International, August 6, 2014    Free full text

13 Propranolol: a novel treatment for angiolymphoid hyperplasia with eosinophilia Clinical and Experimental Dermatology, August 11, 2014

14 Medical marijuana clinical trials: preempted by politics Full Text Applied Clinical Trials, August 15, 2014    Free full text

15 TTIP: From hot tip to oblivion? Pharmaceutical Executive Magazine, August 19, 2014

16 Transparency and sharing: UCB expands access to clinical study data Full Text UCB, August 5, 2014    Free full text

17 Over 1,000 medical sites in the United States now licensed to administer Xofigo (radium Ra 223 dichloride) injection Full Text Bayer HealthCare Pharmaceuticals, August 14, 2014    Free full text

18 Changes and challenges for generic drugs Full Text BioPharm International, August 14, 2014    Free full text

19 Toward a jurisprudence of drug regulation The Journal of Law, Medicine & Ethics, August 5, 2014    Clinical Article

20 First half year 2014: Boehringer Ingelheim meets challenges Full Text Boehringer Ingelheim, August 12, 2014    Free full text

Indexed Journals in Pharma News: U.S.Pharmacist, FDA Drug Alerts, Pharmiwebmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register
Upcoming Clinical Trials UPCOMING Clinical Trials

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close